Polymedication

Polymedication has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Apr 20, 2023: “Adjusted morbidity groups and survival: a retrospective cohort study of primary care patients with chronic conditions”.

Exposure

1 paper studies it1 findingUpdated

See all 1

“polymedication (HR = 2.6; 95% CI = 2.0-3.3)”
Adjusted morbidity groups and survival: a retrospective cohort study of primary care patients with chronic conditionsBMC primary care2023doi:10.1186/s12875-023-02059-9
  • 1 lab in 1 country
  • Humans1

What did studies of Polymedication find?

1

Studies of Polymedication measured 1 outcome; the most studied are survival (1 study).

Survival

downin humans1HR 2.6

1 study
  1. Polymedication decreases survival in humans (HR 2.6, 95% CI 2.0-3.3).

    “polymedication (HR = 2.6; 95% CI = 2.0-3.3)”

    Humansin patients with chronic conditions

    Adjusted morbidity groups and survival: a retrospective cohort study of primary care patients with chronic conditions

    BMC primary care

Latest